Hanno Glimm

发表

Variant classification in precision oncology

Melanie Boerries, Olaf Neumann, Michael Thomas, 2019, International journal of cancer.

From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards

Tim Beißbarth, Barbara Hutter, Benedikt Brors, 2018, Genome Medicine.

Genomics of Immunotherapy-Associated Hyperprogressors—Letter

Peter Horak, Stefan Fröhling, Albrecht Stenzinger, 2017, Clinical Cancer Research.

Succession of transiently active tumor‐initiating cell clones in human pancreatic cancer xenografts

Jürgen Weitz, Christof von Kalle, Benedikt Brors, 2017, EMBO molecular medicine.

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

Hans Martin, Barbara Burwinkel, Rongxi Yang, 2010, Nature Medicine.

Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells

Giusi Moffa, Rainer Spang, Michael Boutros, 2013, Nature Communications.

Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity

Michael Rothe, Christof von Kalle, Raffaele Fronza, 2014, Science Translational Medicine.

Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites.

Christof von Kalle, Richard Gabriel, Hanno Glimm, 2012, Human gene therapy methods.

NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer.

David Bonekamp, Kortine Kleinheinz, Matthias Schlesner, 2018, Cancer discovery.

Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real‐life analysis of three larger gene panels

Olaf Neumann, Michael Thomas, Ivo Buchhalter, 2019, International journal of cancer.

The tRNA methyltransferase Dnmt2 is required for accurate polypeptide synthesis during haematopoiesis

Oliver Popp, Francesca Tuorto, Frank Lyko, 2015, The EMBO journal.

A largely random AAV integration profile after LPLD gene therapy

Stephan Wolf, Raffaele Fronza, Hanno Glimm, 2013, Nature Medicine.

Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo.

Christine Kinnon, Christof von Kalle, Dick de Ridder, 2007, The Journal of clinical investigation.

Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor Modification

Christof von Kalle, Jakub Tolar, Richard Gabriel, 2017, Molecular therapy. Methods & clinical development.

Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy.

Bruce Aronow, Christof von Kalle, Jean Weissenbach, 2007, The Journal of clinical investigation.

Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing

Stephan Wolf, Wei Wang, Richard Gabriel, 2010, Nature Protocols.

Stem-cell gene therapy for the Wiskott-Aldrich syndrome.

Christof von Kalle, Christoph Klein, Rainer Blasczyk, 2010, The New England journal of medicine.

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1

Yang Du, Manuel Grez, Hanno Glimm, 2006, Nature Medicine.

Integrative genomic and transcriptomic analysis of leiomyosarcoma

Roland Eils, Kortine Kleinheinz, Matthias Schlesner, 2018, Nature Communications.

Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls

Peter Horak, Stefan Fröhling, Hanno Glimm, 2016, ESMO Open.

High-resolution insertion-site analysis by linear amplification–mediated PCR (LAM-PCR)

Hanno Glimm, Manfred Schmidt, Kerstin Schwarzwaelder, 2007, Nature Methods.

Comprehensive genomic access to vector integration in clinical gene therapy

Luca Biasco, Alessandro Aiuti, Richard Gabriel, 2009, Nature Medicine.

Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia.

Till Acker, Christof von Kalle, Stefan Fröhling, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analyzing the Number of Common Integration Sites of Viral Vectors – New Methods and Computer Programs

Christof von Kalle, Richard Gabriel, Hanno Glimm, 2011, PloS one.

High-resolution analysis of the human T-cell receptor repertoire

Christof von Kalle, Raffaele Fronza, Hanno Glimm, 2015, Nature Communications.

Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cells.

Axel Benner, Wiebke Werft, Wilko Weichert, 2016, Cancer letters.

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma

Roland Eils, David Bonekamp, Kortine Kleinheinz, 2019, Nature Communications.